Elevated serum level of progranulin is associated with increased mortality in critically ill patients with candidemia
- 20 January 2024
- journal article
- research article
- Published by Elsevier in Microbes and Infection
- Vol. 26 (4) , 105302
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Chongqing Municipality (CSTB2022NSCQ-LZX0017)
- Chongqing Municipal Education Commission (KJZD-K201900405)
- National Natural Science Foundation of China (82070014)
- National Natural Science Foundation of China (82370009)
This publication has 35 references indexed in Scilit:
- Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicansbloodstream infectionBMC Infectious Diseases, 2013
- Insights into the role of progranulin in immunity, infection, and inflammationJournal of Leukocyte Biology, 2013
- Type I Interferons Promote Fatal Immunopathology by Regulating Inflammatory Monocytes and Neutrophils during Candida InfectionsPLOS Pathogens, 2012
- Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysisCritical Care, 2012
- Th17 Cells in Immunity to Candida albicansCell Host & Microbe, 2012
- The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in MiceScience, 2011
- Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical TrialsClinical Infectious Diseases, 2010
- Comparison of albicans vs. non-albicans candidemia in French intensive care unitsCritical Care, 2010
- Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient miceJournal of Experimental Medicine, 2009
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008